Corrigendum: Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials
An Wang, Mengqi Chen, Qi Zhuang, Lihua Guan, Weiping Xie, Lan Wang, Wei Huang, Zhaozhong Cheng, Shiyong Yu, Hongmei Zhou, Jieyan Shen
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
- —National Natural Science Foundation of China10.13039/501100001809
- —Clinical Research Innovation and Incubation Foundation of Renji Hospital, Shanghai Jiao Tong University School of Medicine
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPulmonary Hypertension Research and Treatments
Incorrect Funding
In the published article, there was an error in the Funding statement.
There was an error in specifying the grant number of National Natural Science Foundation of China (CN) in the Funding section of the paper. The correct grant number is [81970047] and [82270050], but it was mistakenly written as [81800047].
The original text was: This work was supported by the National Natural Science Foundation of China (CN) (81800047) and the Clinical Research Innovation and Incubation Foundation of Renji Hospital, Shanghai Jiao Tong University School of Medicine (PYII20-13).
The correct Funding statement appears below.